We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

66 hedge funds and large institutions have $15.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

3% more funds holding

Funds holding: 64 → 66 (+2)

17% less capital invested

Capital invested by funds: $18.4M → $15.3M (-$3.15M)

30% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 20

90% less call options, than puts

Call options by funds: $40K | Put options by funds: $397K

Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
14
Reduced
20
Closed
14
Calls
$40K
Puts
$397K
Net Calls
-$357K
Net Calls Change
-$2.04M

Top Buyers

1
TI
Turner Investments
Pennsylvania
+$671K
2
AllianceBernstein
AllianceBernstein
Tennessee
+$598K
3
Goldman Sachs
Goldman Sachs
New York
+$156K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$126K
5
HighTower Advisors
HighTower Advisors
Illinois
+$108K

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$1.44M
2
State Street
State Street
Massachusetts
-$661K
3
SFM
Sphera Funds Management
Israel
-$476K
4
BIT
BlackRock Institutional Trust
California
-$462K
5
DBG
De Burlo Group
Massachusetts
-$399K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$27K +$29.1K +27 New
WSFS
52
Wilmington Savings Fund Society
Delaware
$25K +$27K +25 New
CLOS
53
Compagnie Lombard Odier SCmA
Switzerland
$20K +$21.6K +20 New
First Manhattan
54
First Manhattan
New York
$18K -$5.39K -5 -22%
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$17K – – –
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
$13K – – –
BIM
57
BlackRock Investment Management
Delaware
$11K -$156K -145 -93%
Wells Fargo
58
Wells Fargo
California
$10K +$5.39K +5 +100%
BJ
59
BlackRock Japan
Japan
$10K +$10.8K +10 New
TRCT
60
Tower Research Capital (TRC)
New York
$10K +$10.8K +10 New
Bank of America
61
Bank of America
North Carolina
$7K -$42.1K -39 -85%
EWM
62
Edge Wealth Management
New York
$5K -$37.7K -35 -88%
AIM
63
Advantage Investment Management
Iowa
$5K +$5.39K +5 New
Citigroup
64
Citigroup
New York
$4K -$3.23K -3 -43%
AIG
65
American International Group
New York
$1.83K -$33.4K -31 -94%
LS
66
Lupo Securities
Illinois
$1K +$1.08K +1 New
SFM
67
Sphera Funds Management
Israel
– -$476K -469 Closed
EIM
68
Essex Investment Management
Massachusetts
– -$190K -187 Closed
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
– -$99K -97 Closed
Charles Schwab
70
Charles Schwab
California
– -$79K -77 Closed
TA
71
Teachers Advisors
New York
– -$74K -72 Closed
SG Americas Securities
72
SG Americas Securities
New York
– -$61K -60 Closed
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
– -$54K -53 Closed
TSS
74
Two Sigma Securities
New York
– -$44K -43 Closed
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$40 -39 Closed
1 2
3
4

NBSE Hedge Fund Activity: Q2 2015 in Review

66 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q2 2015, worth a combined $15.3M — down 17% from $18.4M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NBSE positions and 14 closed out — a net gain of 2 holders — while 14 added to existing stakes and 20 trimmed.

The largest buyer was Turner Investments, adding an estimated $671K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.44M.

  • 66 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q2 2015, up from 64 in Q1 2015.
  • Funds reported $15.3M of NeuBase Therapeutics, Inc. Common Stock stock for Q2 2015, down 17% quarter-over-quarter.
  • 16 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q2 2015 and 14 closed out, a net change of +2 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q2 2015 was Turner Investments, an estimated $671K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.44M sold.

Based on aggregated 13F filings for Q2 2015.